Gastroscopy
Conditions
Interventions
Group 2(Normal size population):Ciprofol
Group 1(People with abdominal obesity):Ciprofol
Sponsors
The First Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients undergoing upper gastrointestinal endoscopy under intravenous anesthesia; 2.ASA grade: I, II, III; 3. Both sexes, aged >=18 years old; 4. Those who can understand the trial protocol and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Contraindications to sedation/anesthesia; 2. Have contraindications to endoscopy (such as acute upper respiratory tract infection, asthma attack, abnormal liver function, etc.); 3. Known to be allergic to eggs, soy products, opioids and their rescue drugs; Difficult airway and hemodynamic instability (e.g., systolic blood pressure 180 mmHg, diastolic blood pressure > 110 mmHg, modified Mallampati class III or IV, or SpO2 < 90% on air inhalation); 5. Obstructive sleep apnea syndrome; 6. Participated in other drug trials within 3 months before the study.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure;Heart rate;SpO2;Adverse Events; | — |
Primary
| Measure | Time frame |
|---|---|
| Anesthesia Efficacy Evaluation; | — |
Countries
China
Contacts
Public ContactXiaopeng Mei
The First Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed